Pharmacy

Conduct medication therapy management for [patient]:

Patient: [age, conditions]
Medications: [current med list]
Lab values: [recent results]
Complaints: [side effects or concerns]
Insurance: [coverage]
Adherence: [compliance]

MTM assessment:
- Medication list review (accuracy)
- Indication for each medication
- Effectiveness assessment
- Safety evaluation (interactions, duplications)
- Adherence barriers identified
- Adverse effects screening
- Renal/hepatic dosing appropriateness
- Cost/insurance issues
- Drug therapy problems identified
- Recommendations to prescriber
- Patient education needs
- Monitoring parameters
- Follow-up plan
- Documentation for billing

Analyze drug interactions for [medication scenario]:

Current medications: [list all]
New medication: [proposed addition]
Patient factors: [age, organ function, conditions]
Lab values: [relevant results]
Symptoms: [if any]

Interaction analysis:
- Drug-drug interactions identified (severity)
- Drug-disease interactions
- Drug-food interactions
- Drug-lab interactions
- Pharmacokinetic interactions (absorption, metabolism, excretion)
- Pharmacodynamic interactions (additive, synergistic, antagonistic)
- Clinical significance assessment
- Timing considerations
- Monitoring recommendations
- Alternative medication suggestions
- Dose adjustments needed
- Patient counseling points
- Prescriber communication
- Documentation

Perform antibiotic stewardship review for [case]:

Patient: [age, weight, allergies]
Infection: [type and location]
Culture data: [organism and sensitivities]
Current antibiotic: [drug, dose, duration]
Renal/hepatic function: [values]
Clinical response: [improving, static, worsening]

Stewardship review:
- Indication appropriateness
- Spectrum of coverage (broad vs narrow)
- Culture-directed therapy opportunity
- Dose optimization (based on PK/PD)
- Route of administration (IV to PO switch)
- Duration assessment (can shorten?)
- Redundant coverage identified
- Allergy verification (true vs intolerance)
- Renal/hepatic dose adjustment
- Monitoring parameters
- De-escalation opportunities
- Cost-effective alternatives
- Resistance prevention strategies
- Recommendation and rationale
- Follow-up timing

Assess immunization needs for [patient]:

Patient: [age, medical conditions]
Immunization history: [documented vaccines]
Travel plans: [if applicable]
Occupation: [risk exposure]
Pregnancy status: [if applicable]
Immunocompromised: [status]

Immunization assessment:
- Age-appropriate vaccines due (per CDC schedule)
- Catch-up vaccines needed
- High-risk condition vaccines
- Occupational vaccines
- Travel vaccines
- Contraindications identified
- Precautions noted
- Timing considerations (intervals, concurrent)
- Product selection
- Administration technique
- Post-vaccination monitoring
- Documentation requirements (VIS provided)
- Adverse event reporting
- Next vaccines due
- Patient education

Address medication non-adherence for [patient]:

Patient: [demographics]
Medications: [regimen]
Adherence rate: [% or description]
Barriers: [identified issues]
Health literacy: [level]
Motivation: [readiness to change]

Adherence intervention:
- Non-adherence type (intentional vs unintentional)
- Barriers assessment (cost, side effects, complexity, forgetfulness, beliefs)
- Health literacy evaluation
- Regimen complexity analysis
- Simplification strategies
- Reminder systems
- Pillbox/organizer recommendation
- Cost reduction strategies (generics, assistance programs)
- Side effect management
- Motivational interviewing approach
- Goal setting with patient
- Teach-back verification
- Follow-up plan (frequency)
- Adherence monitoring method
- Interdisciplinary collaboration

Evaluate suspected adverse drug reaction:

Patient: [age, weight, conditions]
Suspect medication: [drug, dose, duration]
Reaction: [symptoms/signs]
Timing: [when started]
Other medications: [concurrent]
Prior exposures: [history]

ADR assessment:
- Symptom description and severity
- Temporal relationship (Naranjo score)
- Dose-response relationship
- Dechallenge/rechallenge history
- Alternative causes ruled out
- Previous similar reactions
- Mechanism of ADR (Type A-E)
- Causality assessment (definite, probable, possible, unlikely)
- Severity grading
- Management recommendations
- Medication discontinuation vs continuation
- Alternative therapy suggestions
- Allergy documentation (true allergy vs side effect)
- Reporting to MedWatch if serious
- Patient counseling
- Chart documentation

Adjust medications for renal impairment:

Patient: [age, weight]
Serum creatinine: [value]
CrCl or eGFR: [calculated value]
Medications: [current list]
AKI vs CKD: [acute or chronic]
Dialysis: [type and schedule if applicable]

Renal dosing assessment:
- CrCl calculation (Cockcroft-Gault)
- eGFR consideration
- Stage of kidney disease
- Medications requiring adjustment
- Dose adjustment recommendations (by CrCl range)
- Frequency adjustment recommendations
- Medications to avoid
- Nephrotoxic medications identified
- Monitoring parameters
- Alternative medications if needed
- Dialyzability of medications
- Post-dialysis dosing
- Drug accumulation risk
- Patient education
- Prescriber communication
- Reassessment triggers

Manage anticoagulation therapy for [indication]:

Patient: [age, weight, indication]
Anticoagulant: [warfarin, DOAC, etc.]
Target INR/range: [if warfarin]
Last INR: [value and date]
Bleeding risk: [score]
Recent changes: [diet, meds, illness]

Anticoagulation management:
- Indication verification
- Appropriate agent selection
- Dose assessment
- INR interpretation (if warfarin)
- Dose adjustment algorithm
- Drug interactions affecting anticoagulation
- Food interactions (vitamin K)
- Bridging needs for procedures
- Bleeding risk assessment (HAS-BLED)
- Fall risk consideration
- Monitoring schedule
- Patient education (diet, missed doses, bleeding signs)
- When to hold medication
- Emergency reversal plan
- Follow-up timing
- Laboratory monitoring

Optimize pain medication regimen for [patient]:

Patient: [age, pain type]
Current pain meds: [opioids, NSAIDs, adjuvants]
Pain level: [scale and description]
Side effects: [constipation, sedation, etc.]
Risk factors: [substance use, renal, hepatic]
Function: [impact on activities]

Pain regimen optimization:
- Pain assessment (type: nociceptive vs neuropathic)
- Current regimen effectiveness
- Opioid conversion if switching
- Morphine equivalent daily dose (MEDD)
- Multimodal approach (non-opioid adjuncts)
- Scheduled vs PRN dosing
- Breakthrough pain management
- Side effect management (bowel regimen)
- Non-pharmacologic strategies
- Risk mitigation (prescription monitoring program check)
- Tapering plan if appropriate
- Monitoring parameters
- Red flags for misuse
- Patient education and agreement
- Prescriber recommendations
- Reassessment timeline